Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin 17C (IL-17C) is a cytokine belonging to the IL-17 family, primarily produced by epithelial cells. It plays a crucial role in mucosal immunity, inflammation, and autoimmune disease by maintaining epithelial barrier integrity, inducing antimicrobial peptides, and promoting the recruitment of immune effector cells. It signals through a heterodimeric receptor complex of IL-17RA and IL-17RE. Dysregulation of IL-17C is implicated in various chronic inflammatory and autoimmune diseases, making it a potential therapeutic target.
Modulation of IL-17RA/RE signaling, inhibition of downstream pathways (NF-kB, MAPK, Bcl2/Bcl-xL)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 17C (IL-17C).